TelyRx Holdings Inc. faced a significant decline of 17.55% in its stock price during the last trading session, raising concerns among investors.
TelyRx Holdings Inc. (TELY.TO) saw its stock close at CA$2.02 after a sharp drop of 17.55%. This downturn has left investors questioning the company's stability and future prospects, especially with an upcoming investor conference on the horizon.
Investor takeaway: Investors should keep a close eye on TelyRx's upcoming presentations and how the market reacts. The recent price drop may indicate broader concerns about the company's performance and market position.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$77.08M
52W high
$4.25
52W low
$2.00
1W change
+20.83%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 106.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+106.9% Upside
Current Price
C$2.90
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
102.8%
Annualized
90-Day Vol
99.7%
Annualized
Trend (90d)
-14.2%
Annualized drift
90d Mean
C$2.76
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.85 | C$2.00 โ C$4.06 |
| 60 trading days | C$2.80 | C$1.70 โ C$4.63 |
| 90 trading days | C$2.76 | C$1.49 โ C$5.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Bull case
The upcoming Small Cap Growth Virtual Investor Conference could be a chance for TelyRx to clarify its strategy and reassure investors. If they effectively communicate their plans, it might help reverse the negative sentiment surrounding the stock.
Bear case
The significant price drop raises concerns about investor confidence and could signal deeper issues within the company's operations or market strategy. If these issues aren't addressed, further declines may follow.
Market Reaction
The 17.55% drop in TelyRx's stock price reflects a substantial loss of investor confidence. With a market cap now at CA$66.4 million, this decline raises questions about the company's operational health and future growth prospects. Investors should carefully assess the implications of this downturn.
Upcoming Investor Conference
TelyRx is scheduled to present at the Small Cap Growth Virtual Investor Conference on June 4, 2026. This event could be crucial for the company to address investor concerns and outline its strategic direction. Investors should consider attending or reviewing the conference to look for signs of potential recovery for TELY.TO.
Long-Term Considerations
While today's decline is concerning, TelyRx's long-term success will depend on its ability to innovate and adapt in the competitive healthcare market. Investors should monitor the company's performance metrics and market positioning as they navigate through this challenging phase.
Advertisement
